Cimetidine is critical in CNS disorders
dc.contributor.author | Shayanfar, A | |
dc.contributor.author | Gharekhani, A | |
dc.contributor.author | Ghasemian, E | |
dc.date.accessioned | 2018-08-26T08:38:55Z | |
dc.date.available | 2018-08-26T08:38:55Z | |
dc.date.issued | 2009 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52975 | |
dc.description.abstract | There are many CNS disorders with imbalance of dopamine in brain. Cimetidine adversely increases serum level of the prolactin and leads to activate feedback control to decrease prolactin release and intensifies synthesis and secretion of dopamine. Thus, cimetidine can be critical in CNS disorders. é 2009 Elsevier Ltd. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Bioscience Hypotheses | |
dc.subject | cimetidine | |
dc.subject | dopamine | |
dc.subject | prolactin | |
dc.subject | article | |
dc.subject | central nervous system disease | |
dc.subject | dopamine metabolism | |
dc.subject | dopamine release | |
dc.subject | feedback system | |
dc.subject | human | |
dc.subject | prolactin blood level | |
dc.subject | prolactin release | |
dc.title | Cimetidine is critical in CNS disorders | |
dc.type | Article | |
dc.citation.volume | 2 | |
dc.citation.issue | 3 | |
dc.citation.spage | 180 | |
dc.citation.epage | 181 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1016/j.bihy.2009.01.003 |
فایلهای درون آیتم
فایلها | سایز | فرمت | نمایش |
---|---|---|---|
هیچ فایل مرتبطی وجود ندارد |